The press releases contained in this section are provided for historical purposes only. The information contained in each press release is accurate only as of the date each press release was originally issued. Medicis has no obligation to update any information contained in such press releases after the date of their issuance. For current information about the Company, please refer to our most recent public filings with the Securities and Exchange Commission.

Receive all Medicis news via e-mail

View the Medicis News Archive

Fiscal Year 2004 News Archive
Jun 21, 2004
Medicis Announces Fiscal 2005 Guidance
Jun 18, 2004
Medicis to Present at Wachovia Securities Equity Conference
Jun 10, 2004
Medicis Declares Cash Dividend
Jun 9, 2004
Medicis to Present at Thomas Weisel Partners Growth Forum 6.0
Jun 1, 2004
Complaint Against Medicis Filed by Inamed
May 19, 2004
Medicis to Present at UBS Global Specialty Pharmaceuticals Conference
May 18, 2004
Medicis Closes License of ORAPRED to BioMarin with Option to Purchase
May 3, 2004
Medicis to Present at Smith Barney Citigroup Small & Mid-Cap Conference
Apr 29, 2004
Medicis Reports Third Quarter Fiscal 2004 Financial Results
Apr 28, 2004
Medicis to Present at Deutsche Bank Securities 29th Annual Health Care Conference
Apr 20, 2004
Medicis Licenses ORAPRED to BioMarin With Option to Purchase
Apr 14, 2004
Medicis Announces Third Quarter Fiscal 2004 Conference Call and Webcast
Mar 16, 2004
Medicis Declares Cash Dividend
Feb 19, 2004
Medicis to Present at Smith Barney 4th Annual Specialty Pharmaceuticals Conference
Feb 2, 2004
Medicis to Present at 2004 Merrill Lynch Global Pharmaceutical, Biotechnology & Medical Device Conference
Jan 22, 2004
Medicis Reports Second Quarter Fiscal 2004 Financial Results
Jan 16, 2004
Medicis Announces Second Quarter Fiscal 2004 Conference Call and Webcast
Jan 8, 2004
Medicis to Present at 22nd Annual J.P. Morgan Healthcare Conference
Jan 6, 2004
Medicis Announces First Shipment of RESTYLANE to Physicians
Jan 2, 2004
Medicis Announces 2 for 1 Stock Split
Dec 22, 2003
Medicis Discontinues PVAC Development
Dec 16, 2003
Medicis Declares Cash Dividend
Dec 12, 2003
Medicis Announces FDA Approval of Restylane, the First and Only Dermal Filler Made of Stable, Biodegradable Non-Animal Hyaluronic Acid
Nov 21, 2003
Medicis Announces RESTYLANE's Recommendation from FDA Advisory Panel
Nov 21, 2003
Medicis Stock Trading to Halt as FDA Advisory Panel Reviews RESTYLANE
Nov 20, 2003
Medicis Announces FDA Advisory Panel Information Available on FDA Website
Nov 19, 2003
Medicis Announces Conference Call to Review FDA Advisory Panel Proceedings
Oct 30, 2003
Medicis Reports First Quarter Fiscal 2004 Financial Results
Oct 27, 2003
Medicis Announces First Quarter Fiscal 2004 Conference Call and Webcast
Sep 19, 2003
Medicis Declares Cash Dividend
Sep 10, 2003
Medicis Announces FDA Advisory Panel for RESTYLANE
Aug 28, 2003
Medicis to Present at Thomas Weisel Partners Healthcare Tailwinds 2003 Conference
Aug 26, 2003
Medicis Reports Fourth Quarter and Year-End Fiscal 2003 Financial Results
Aug 21, 2003
Medicis Announces Fiscal 2003 Fourth Quarter and Year-End Conference Call and Webcast
Aug 18, 2003
Medicis Announces Successful Completion of Exchange Offer
Aug 13, 2003
Medicis Announces Initial Results of Exchange Offer
Jul 16, 2003
Medicis Files Exchange Offer for Convertible Notes


© 1996-2008 Medicis Pharmaceutical Corp